International journal of nanomedicine
International journal of nanomedicine is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 193. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on nanomedicine, nanotechnology. It has an SJR impact factor of 1,306 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,306.
International journal of nanomedicine focuses its scope in these topics and keywords: cancer, nanoparticles, model, synthesis, gold, cells, carbon, magnetic, glycol, targeting, ...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,306
H-index
193
Docs (year)
727
Docs 3y
1323
Total refs
58448
Cites 3y
10068
Citable 3y
1314
Cites/Doc 2y
6.69
Ref/Doc
80.4
Immediate OA
2079 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology
View moreTertiary structural analysis of the elongated part of an abnormal hemoglobin, hemoglobin Pakse
View moreSpatial control over cell attachment by partial solvent entrapment of poly lysine in microfluidic channels
View moreWhere is the weak linkage in the globin chain?
View moreWelcome to the international journey to improving human health
View moreTargeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870)
View moreSynthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery
View moreSurface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery
View moreTargeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
View morePotential diagnostic applications of biosensors: current and future directions
View morePolydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents
View morePeptide crosslinked micelles: a new strategy for the design and synthesis of peptide vaccines
View morePropaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles
View moreOptimizing efficacy of amphotericin B through nanomodification
View moreOn the way to building an integrated computational environment for the study of developmental patterns and genetic diseases
View moreNeurite development in PC12 cells cultured on nanopillars and nanopores with sizes comparable with fi lopodia
View moreNanopillar array structures for enhancing biosensing performance
View moreNanomedicines in the treatment of patients with hepatitis C co-infected with HIV ? focus on pegylated interferon-alpha
View moreNanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant
View moreNanomedicines in the treatment of chronic hepatitis C ? focus on pegylated interferon alpha-2a
View moreNanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)
View moreNanomedicines in the treatment of acromegaly: focus on pegvisomant
View moreNanomedicines in renal transplant rejection ? focus on sirolimus
View moreNanomedicine: what's in a definition?
View more